Woman and Man
- | Country :
- Finland
- | organs : -
- | Specialty : -
Extract
This single arm study will assess the safety and efficacy of tocilizumab in patients with moderate to severe active rheumatoid arthritis who have an inadequate response to current non-biologic DMARDs. Patients will receive iv infusions of tocilizumab 8mg/kg every 4 weeks for a total of 6 infusions, either as monotherapy or in combination with their current non-biologic DMARDs.
Inclusion criteria
- Rheumatoid Arthritis